Literature DB >> 4125186

Serum-transaminase activities in liver disease.

F De Ritis, M Coltorti, G Giusti.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1972        PMID: 4125186     DOI: 10.1016/s0140-6736(72)90487-4

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  7 in total

1.  The SGOT/SGPT ratio--an indicator of alcoholic liver disease.

Authors:  J A Cohen; M M Kaplan
Journal:  Dig Dis Sci       Date:  1979-11       Impact factor: 3.199

Review 2.  Clinical use of serum enzymes in liver disease.

Authors:  J J Reichling; M M Kaplan
Journal:  Dig Dis Sci       Date:  1988-12       Impact factor: 3.199

3.  Aspartate aminotransferase-immunoglobulin complexes in patients with chronic liver disease.

Authors:  Masahiko Tameda; Katsuya Shiraki; Kinue Ooi; Koujirou Takase; Yoshitane Kosaka; Tsutomu Nobori; Yukihiko Tameda
Journal:  World J Gastroenterol       Date:  2005-03-14       Impact factor: 5.742

4.  Progression of fibrosis during chronic hepatitis C is associated with rapid virus evolution.

Authors:  Xiao-Hong Wang; Dale M Netski; Jacquie Astemborski; Shruti H Mehta; Michael S Torbenson; David L Thomas; Stuart C Ray
Journal:  J Virol       Date:  2007-02-28       Impact factor: 5.103

5.  Effects of occupational exposure to 1,4-dichlorobenzene on hematologic, kidney, and liver functions.

Authors:  Pao-Kuei Hsiao; Yi-Chang Lin; Tung-Sheng Shih; Yin-Mei Chiung
Journal:  Int Arch Occup Environ Health       Date:  2009-02-27       Impact factor: 3.015

6.  Performance and Value of IFN-Lambda3 and IFN-Lambda4 Genotyping in Patients with Chronic Hepatitis C (CHC) Genotype 2/3 in a Real World Setting.

Authors:  Steffen B Wiegand; Benjamin Heidrich; Simone Susser; Magdalena Rogalska-Taranta; Jörg Petersen; Klaus H W Böker; Natalia Grigorian; Ralph Link; Uwe Naumann; Christine John; Stefan Lueth; Peter Malfertheiner; Michael P Manns; Heiner Wedemeyer; Christoph Sarrazin; Markus Cornberg
Journal:  PLoS One       Date:  2015-12-23       Impact factor: 3.240

7.  Combination Treatment of Omega-3 Fatty Acids and Vitamin C Exhibited Promising Therapeutic Effect against Oxidative Impairment of the Liver in Methotrexate-Intoxicated Mice.

Authors:  Mohammed Alorabi; Doha Saad Mohammed; Gomaa Mostafa-Hedeab; Suzy A El-Sherbeni; Walaa A Negm; Ali Ismail A Mohammed; Hayder M Al-Kuraishy; Nani Nasreldin; Saqer S Alotaibi; Bashir Lawal; Gaber El-Saber Batiha; Carlos Adam Conte-Junior
Journal:  Biomed Res Int       Date:  2022-04-20       Impact factor: 3.246

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.